Despite Minnesota-based Medtronic’s announcement that the federal government has closed its investigation into the marketing of a bone growth agent called Infuse, the company’s legal troubles are not over.
According to an article in the Pioneer Press, a number of other legal inquiries are ongoing into claims that the company promoted Infuse for off-label uses, despite reports that such uses were causing serious and permanent injuries to patients.
They include a subpoena the California Attorney General’s office issued in 2011, and several ...
continue reading...
A recent report on CBS’s 60 Minutes questions whether antidepressants are any more effective than placebos.
Fox News gives an account of a man who survived a two-and-a-half-foot blood clot stretching from his knee to his abdomen.
Johnson & Johnson officials hope the $19.7 billion acquisition of Synthes, which makes surgical trauma equipment and orthopedic implants, will give the company a dominant position in the orthopedic surgery market.
